SecBot SecBot
PRESS-RELEASE ·Filed May 26, 2026

QUCY

Quantum Cyber
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago WireGlobeNewswire
Press release · Regulatory
Actionable Insight ▲ Bullish

The elimination of warrant overhang and debt, combined with a $15M cash infusion, removes two major overhangs and provides a clean balance sheet for M&A. Watch for acquisition announcements and next quarterly update on cash burn and pipeline progress.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
QUCY ▼ -58.50% at T+60d
LONG call ✗ call lost -58.50% · α vs SPY -61.23% · entry $3.47 → $1.44
Entry = T+0 close
May 26, 2026
via day close
T+1d
-15.56%
call -15.56% · α -15.58%
$2.93
settled 5mo ago
T+5d
-35.73%
call -35.73% · α -36.82%
$2.23
settled 5mo ago
T+20d
-59.65%
call -59.65% · α -57.71%
$1.40
settled 4mo ago
T+60d
-58.50%
call -58.50% · α -61.23%
$1.44
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Quantum Cyber announced that all outstanding warrants have been fully exercised, generating over $15 million in gross proceeds. The company is now debt-free with no exercisable warrants remaining, and plans to use the funds for R&D, commercialization, and strategic acquisitions in the autonomous defense sector.

Key Financial Metrics

Deal Value
$15.0M

Key Facts

  • Warrant holders fully exercised outstanding warrants, yielding over $15 million in gross proceeds.
  • Company is now debt-free with no remaining exercisable warrants.
  • Current shares outstanding: 22,767,254.
  • Proceeds to fund R&D expansion, commercialization team build-out, and strategic acquisitions.
  • Management cites alignment with $55 billion U.S. DoD drone procurement budget and counter-UAS market growth from $3.1B to $10.6B by 2030.

Financial Impact

Over $15 million in gross proceeds from warrant exercises; all debt retired.

cashdebtdilution

Risk Factors

  • Execution risk on deploying proceeds into R&D and acquisitions.
  • Dilution from the 22.8M shares outstanding may pressure near-term stock price.
  • Forward-looking statements on market growth may not materialize.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3300983
35 reports for QUCY
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 5 of 6 best @ T+60▲ +39.06%Jun 4, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 2/10
—awaiting T+20——
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$1.07awaiting T+20—$1.01 (−5.61%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.03awaiting T+20—$1.01 (−1.94%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 7/10
$1.03awaiting T+20—$1.01 (+1.94%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$1.36 $0.8515▼ −37.39%▼ −37.36%$1.01 (−25.74%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$1.01 (−26.28%)
Sep 25, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$1.01 (−26.28%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$1.42 $1.34▼ −5.63%▼ −3.89%$1.01 (−28.87%)
Jul 24, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$1.08 $1.30▲ +20.37%▲ +16.74%$1.01 (−6.48%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$1.19awaiting T+20—$1.01 (−15.13%)
Showing 10 of 35

US Market Status

Market Closed — Opens Wed (11h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026